PERRIGO Co (PRGO, Drugmakers) Stock Valuation & Fair Value
Mixed on our testsPERRIGO Co (PRGO, Drugmakers) trades at a current P/E of 6.9, about 60% below its historical normal valuation, with a forward growth estimate of 6.9% and a PEG of 1.01. Analysts' one-year estimates have been hit 18% of the time. Priced at its historical normal P/E of 17.2 on the same blended earnings, the 2026-11-06 close of $15.85 corresponds to about $39.30 a share. This is a valuation reference, not a price target.
How to read these numbers: the PEG ratio and current P/E versus normal P/E.
- Price $15.85 at the Nov 6 close, 0.5% below the 20-day average ($15.93) and 5.9% above the 50-day ($14.96).
- RSI (14) at 55.8.
- 52-week range $8.83 to $16.63: the price is 4.7% below the high and 79.5% above the low.
The Street vs SeerForecast
Wall Street's mean price target for PRGO is $17.00 across 4 analysts, 7.3% above the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.
Valuation flags
- Profitable in none of the last 3 reported years
- Long-term debt is over half its capital (60%)
- Misses analyst estimates often (82%)
Verdict history
tickerseer's rating has been mixed on our tests since 2026-07-31.
Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.
Selected weeks: the first, the latest, and the cheapest and dearest.
Show all 29 readings
Frequently asked questions
Is PERRIGO Co stock overvalued?
At a current P/E of 6.9 versus its historical normal P/E of 17.2, PERRIGO Co trades about 60% below its typical valuation, with a PEG of 1.01 on 6.9% forward growth. tickerseer currently rates it mixed on our tests.
What is PERRIGO Co's fair value and PEG?
PERRIGO Co trades at a current P/E of 6.9 against a historical normal P/E of 17.2, a PEG of 1.01, and a forward growth estimate of 6.9%. Priced at its historical normal P/E of 17.2 on the same blended earnings, the 2026-11-06 close of $15.85 corresponds to about $39.30 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of PERRIGO Co changed?
tickerseer's rating has been mixed on our tests since 2026-07-31.
What is the analyst price target for PERRIGO Co?
The mean Wall Street price target for PERRIGO Co is $17.00 across 4 analysts, 7.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Drugmakers. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.